MTNB Matinas Biopharma Holdings Inc

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company engaged in identifying & developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections.

$0.75  0.00 (0.00%)
As of 05/27/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/21/2014
Outstanding shares:  216,864,526
Average volume:  429,424
Market cap:   $151,761,795
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -24.28
PB ratio:   3.41
PS ratio:   -4,557.41
Return on equity:   -50.97%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy